Furthermore, the mutated IDH1 protein acquires the ability to convert α-ketoglutarate to (R)-2-hydroxyglutarate (2-HG) which could act as an oncometabolite and DJ-1 could exert a potential protective role against oxidative stress in the tumor cells potentially triggered by 2-HG. This evidence concerns the gene IDH1 and neoplasm.